Innovative AI Approach to Rare Disease Diagnosis

Researchers at Shanghai Jiao Tong University’s School of Artificial Intelligence and Xinhua Hospital created DeepRare, an artificial‑intelligence system designed to mimic the diagnostic reasoning of human doctors. Unlike earlier black‑box models, DeepRare integrates forty specialized digital tools and follows an explicit workflow that forms hypotheses, tests them against patient data, searches medical literature, analyzes genetic variants, and iteratively revises conclusions before ranking possibilities.

Head‑to‑Head Performance Against Experienced Physicians

In a direct comparison with five physicians each having more than a decade of practice, DeepRare demonstrated higher diagnostic accuracy. The AI correctly identified the disease on its first suggestion 64.4% of the time, while doctors achieved 54.6% accuracy. When allowed to present three possible diagnoses, DeepRare’s success rose to 79% versus 66% for the clinicians. Moreover, physicians endorsed the AI’s reasoning 95.4% of the time, indicating that the system’s explanations were persuasive and medically sound.

Real‑World Deployment and Reach

Since July 2025, DeepRare has been available on an online diagnostic platform. More than six hundred medical institutions worldwide have registered to use the system, moving it beyond the laboratory into everyday clinical practice. The research team plans further validation with twenty thousand real‑world cases and intends to launch a global rare‑disease diagnostic alliance.

Potential Impact on Patients

Rare diseases affect roughly three hundred million people worldwide, and patients often endure a diagnostic odyssey that can stretch five years or longer. Each year of delay can mean missed treatment opportunities and accumulating organ damage. By offering rapid, accurate suggestions and surfacing possibilities that might be overlooked, DeepRare has the potential to trim weeks or months from that timeline, improving outcomes for millions.

Role of AI in Clinical Care

The authors stress that DeepRare is not intended to replace clinicians but to augment diagnostic workflows. This stance acknowledges both the technical limits of AI and the essential human elements of medicine, positioning the system as a decision‑support tool that enhances, rather than supplants, physician expertise.

Used: News Factory APP - news discovery and automation - ChatGPT for Business